ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 36.5 | 38.4 | 43.2 |
| Other income | -0.5 | 0.9 | 1.1 |
| Total income | 36.0 | 39.3 | 44.2 |
| Profit before exceptional items & tax | 2.5 | 3.5 | 3.3 |
| Profit before tax | 2.5 | 3.5 | 3.3 |
| Net profit | 2.0 | 2.4 | 2.0 |
| Operating margin | 6.9% | 8.9% | 7.5% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Net profit, quarter on quarter | -16.70% |
| Revenue, year on year | -15.50% |
BSE results filing, NSE: ARCHITORG. Figures extracted from the filing.
Archit Organosys Ltd: key numbers
- Share price
- ₹67.66
- Market cap
- ₹138.8 Cr
- Revenue (annual)
- ₹140.9 Cr
- Net profit (annual)
- ₹8.03 Cr
- P/E (TTM)
- 18.6×Sector 35.1×
- Promoter holding
- 65.88%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Archit Organosys Ltd
All →Archit Organosys Q2 FY27 Results: Net Profit ₹1.5 Cr, Up 0.0% YoY
Archit Organosys approved unaudited results for the quarter and half year ended September 30, 2026. The auditor's limited review report is attached.
- Key figure
- Net profit ₹1.5 Cr · +0.0% YoY
Archit Organosys Board Meeting Date
Archit Organosys will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window has been closed since October 1, 2026.
Archit Organosys Other Announcement
A standard quarterly shareholding pattern filing submitted by Archit Organosys Ltd as per SEBI Regulation 31(1)(b) requirements.
Archit Organosys Annual General Meeting
Archit Organosys Limited submitted the voting results of its 33rd Annual General Meeting held on September 30, 2026. All resolutions were passed by the shareholders.
Archit Organosys Annual Report
Archit Organosys Limited issued a corrigendum to its FY 2025-26 Annual Report, withdrawing Agenda Items 8, 9, and 10 from the upcoming AGM notice.
Archit Organosys Annual General Meeting
Archit Organosys has withdrawn three agenda items from the upcoming AGM, including an authorised capital increase, an acquisition, and a proposed preferential issue for restructuring.